VFA
BBNX

Values First Advisors’s Beta Bionics BBNX Stock Holding History

Values First Advisors’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$476K Buy
47,551
+12,360
+35% +$183K 0.25% 102
2025
Q4 		$1.07M Sell
35,191
-5,274
-13% -$141K 0.56% 57
2025
Q3 		$804K Sell
40,465
-2,098
-5% -$36.9K 0.43% 66
2025
Q2 		$620K Buy
42,563
+4,978
+13% +$70.5K 0.34% 84
2025
Q1 		$457K Buy
+37,585
New +$701K 0.27% 103

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Values First Advisors's BBNX Position: Q1 2026 in Review

Values First Advisors increased its Beta Bionics (BBNX) stake by 35% in Q1 2026, buying an estimated $183K and bringing the position to 47,551 shares worth $476K. The position accounts for 0.25% of the portfolio, ranked #102.

Values First Advisors first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.07M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Values First Advisors held 47,551 shares of Beta Bionics worth $476K as of Q1 2026.
  • Values First Advisors bought 12,360 Beta Bionics shares in Q1 2026, an estimated $183K.
  • Beta Bionics made up 0.25% of Values First Advisors's portfolio in Q1 2026, its #102 holding.
  • Values First Advisors first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Values First Advisors's Beta Bionics position peaked at $1.07M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Values First Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.